Gyre Therapeutics, Inc. GYRE Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s change in inventories?
- Gyre Therapeutics, Inc. (GYRE) reported change in inventories of $1.02M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s change in inventories changed year-over-year?
- Gyre Therapeutics, Inc.'s change in inventories decreased by 34.1% year-over-year, from $1.54M to $1.02M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s change in inventories?
- Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s change in inventories has grown at a 61.5% compound annual growth rate (CAGR), from $879K to $3.7M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.